C. Bunick, “Investigator- and Patient-Rated Local Tolerability in Phase 3 Trials of Topical Roflumilast in Patients With Psoriasis, Seborrheic Dermatitis, and Atopic Dermatitis”, J of Skin, vol. 8, no. 1, p. s309, Jan. 2024.